Skip to main content

Radiofrequency Ablation Devices Market is Growing at a Healthy CAGR of 11.2% During Forecast to 2023


Market Outlook:
Rising number of cases of chronic diseases, the geriatric populace, and the emergence of minimally invasive surgeries can fuel the market growth. According to the World Health Organization (WHO), the geriatric population number can touch 2 billion by 2050. Treatment of cancer and its recurrence by RFA can bolster the global radiofrequency ablation devices market. The healthcare spending in the U.S. is also an indicator of the dire need for RFA devices.
Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/7634
The global Radiofrequency Ablation Devices Market size is projected to expand at 11.2% CAGR over the forecast period. The treatment of dysplastic Barrett’s esopohagus (BE) is one of the primary drivers of the market. Preference of RFA over other ablation procedures and its high success rate can induce the demand for these devices in hospitals, clinics, and ambulatory care services.

Competition Outlook:
AtriCure, Inc., Medtronic Inc, RF Medical Co, Ltd, Stryker, St. Jude Medical, Smith & Nephew, Boston Scientific Corporation, Angiodynamics, Cosman Medical, Inc., Johnson & Johnson (J&J) Services, LLC
Segmentation:
·         The global radiofrequency ablation devices market is segmented on the basis of type and application.
·         On the basis of the type, the global radiofrequency ablation devices market is segmented into unipolar radiofrequency ablation and bipolar radiofrequency ablation.
·         By application, the global radiofrequency ablation devices market is segmented into cosmetology, surgical oncology, gynecology, cardiology and cardiac rhythm management, and pain management.
Regional Analysis:
The Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA) are regions covered in the global radiofrequency ablation devices market.
The Americas dominates the global market for radiofrequency ablation devices due to the increasing number of lung cancer cases such as non-small cell lung cancer (NSCLC). It accounted for 80-85% of all lung cancer cases. Small cell lung cancer accounts for 12-13% of lung cancers. However, the shift from NSCLC to SCLC in recent years is likely to propel the growth of the radiofrequency ablation devices market. Large number of cases of tumors, chronic pain, and other rare diseases can warrant the need for RFA devices.
In 2017, it was estimated that Europe will grab the second position in the global radiofrequency ablation devices market. Presence of various manufacturers and entry of catheter manufacturers can fuel the market growth.
APAC was the fastest growing region for the global radiofrequency ablation devices market in 2017. Factors such as increasing awareness of cardiovascular diseases, growth of the healthcare industry, and the development of various treatment methods for gynecology and cosmetology can drive the market in this region. Improvements in economic conditions and rise in disposable income levels of patients can fuel the regional market growth.
On the other hand, the Middle East and Africa holds the least share in the global radiofrequency ablation devices market. The presence of poor economies and low per capita income, especially within the African region make the market to lag within the region. A majority of the market share within this region is estimated to be held by the Middle East due to increasing government funding in the healthcare for healthcare, and presence of developed economies like UAE, Kuwait, Dubai, and others.



Labels:

Comments

Post a Comment

Popular posts from this blog

Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis and Forecast to 2023

Market Overview: The Global Respiratory Therapeutic Devices Market is predicted to scale to new heights and expand at a CAGR of 10.8% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in an in-depth study.                   The growth of the Global Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis   is primarily led by the recent surge in the incidence of chronic respiratory diseases such as asthma, COPD, and sleep disorder breathing. As per the estimates of the World Health Organization (WHO), approximately 235 Mn people suffered from asthma in 2017 across the globe. The growing burden of chronic respiratory diseases (CRDs) induces strong demand for respiratory therapeutic devices within the market. Moreover, with the increase in the global aging population, there is a greater need for respiratory therapeutic devices.     ...
Post a Comment
Read more

Antibody Drug Conjugate Market is Presumed to Grow at a Reliable CAGR of 19% During Forecast to 2023

Antibody Drug Conjugate Market Analysis: Various factors are adding to the global antibody drug conjugate market share. These factors, as per the new MRFR report, include advances in medical technology, rising cases of cancer, growing obese population, and increasing aging population. Additional factors adding market growth include increasing collaborations between biotechnology companies, biopharmaceuticals, and research institutes, rising R&D on oncology diseases, increasing research on advanced drug discoveries, rising number of research on antibody therapies, and preclinical research. The global Antibody Drug Conjugate Market Share is likely to grow at a 19% CAGR between 2017- 2023 , reveals the new Market Research Future (MRFR) report. Antibody drug conjugates are new-age therapeutic agents that have three parts- a chemical linker to attach cytotoxic agents to antibodies, cytotoxic agents for killing target cancer cells, and specific antibodies for binding. Lymphoma, mult...
Post a Comment
Read more

Desalting and Buffer Exchange Market is Growing at a Healthy CAGR of 10.5% During Forecast to 2023

Market Highlights: The Global Desalting and Buffer Exchange Market is anticipated to have held a market value of USD 615.20 million in the year 2017 and is expected to grow at a CAGR of 10.5% during the forecast period. Desalting and buffer exchange play a key role in biotechnological companies. Buffer exchange is used to place a protein solution into a more suitable buffer before applications such as electrophoresis, ion exchange, affinity chromatography among others. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6633 Buffer exchange is the term used when one set of buffer salts in a sample is exchanged by another more appropriate buffer set. The rising demand for monoclonal antibodies, growing research and development expenditure by the biopharmaceutical companies, and rising focus on proteomic and genomic research is anticipated to boost the growth of the market over the forecast period. However, the dearth of skilled professionals is excepted to ...
Post a Comment
Read more